Science Center Awards $600,000 to Researchers at Three Universities Through QED Program

Dear Colleagues,

Four promising technologies are one step closer to the marketplace thanks to funding from the University City Science Center’s QED Proof-of-Concept Program. Life science and health IT researchers from Drexel University, Temple University and Rutgers, The State University of New Jersey, received a total of $600,000 through the QED program to develop a potential drug therapy for Lou Gehrig’s disease; validate a new therapeutic compound for pancreatic cancer; develop software to analyze EEG readings and guide diagnosis; and improve communications skills of health care professionals.

Details are included in the attached press release which was distributed via Business Wire. To view the release online go to:




Jeanne Mell
VP Marketing Communications
University City Science Center
3711 Market Steet, Suite 800
Philadelphia, PA 19104



©2020 PACT All Rights Reserved